EP3773910
MANNGERÐAR MÓTEFNALYFJASAMTENGINGAR GEGN BLÖÐRUHÁLSKIRTILSSÉRTÆKUM HIMNUMÓTEFNAVAKA (PSMA)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.3.2019EP published:
24.7.2024EP application number:
19717173.9
EP translation filed:
29.8.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
28.3.2039Expiry date:
28.3.2027Next due date:
31.3.2027
Title in English:
HUMANIZED ANTI-PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) ANTIBODY DRUG CONJUGATESLanguage of the patent:
English
Timeline
Today
29.3.2019EP application
24.7.2024EP Publication
29.8.2024Translation submitted
15.10.2024Registration published
28.3.2027Expires
Owner
Name:
Ambrx, Inc.Address:
10975 North Torrey Pines Road, La Jolla, CA 92037, US
Inventor
Name:
BHOWMIK, ShivarupamAddress:
San Diego, CA 92128, US
Name:
WANG, JianingAddress:
Cambridge, MA 02138, US
Name:
XIA, JinmingAddress:
Oceanside, CA 92057, US
Name:
BRADY, WilliamAddress:
Bothell, WA 98021, US
Name:
TIAN, FengAddress:
San Diego, CA 92129, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862650277 PDate:
29.3.2018Country:
US
Classification
Categories:
A61P 35/00, C07K 16/30, A61K 47/68
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 14.2.2025
Expires: 28.3.2026
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.3.2026
Expires: 28.3.2027
Payer: Árnason Faktor ehf.